Association of promoter polymorphism -765G>C in the PTGS2 gene with malignant melanoma in Italian patients and its correlation to gene expression in dermal fibroblasts

Experimental Dermatology

Volumn 23, Issue 10, 2014, Pages 766-768

  Gomez Lira, Macarena ^a   Ferronato, Silvia ^a   Malerba, Giovanni ^a   Santinami, Mario ^b   Maurichi, Andrea ^b   Sangalli, Antonella ^a   Turco, Alberto ^a   Perego, Paola ^b   Rodolfo, Monica ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Expression analysis; Malignant melanoma; Promoter polymorphisms; PTGS2

Indexed keywords

CYCLOOXYGENASE 2; CYSTEINE; GLYCINE; PTGS2 PROTEIN, HUMAN;

ALLELE; CANCER PATIENT; CONTROLLED STUDY; CORRELATIONAL STUDY; CUTANEOUS MELANOMA; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; ITALIAN (CITIZEN); LETTER; MAJOR CLINICAL STUDY; METASTATIC MELANOMA; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BIOPSY; SKIN FIBROBLAST; ADULT; AGED; CASE CONTROL STUDY; ENZYMOLOGY; FEMALE; FIBROBLAST; GENETICS; ITALY; MALE; MELANOMA; MIDDLE AGED; SKIN; SKIN TUMOR;

ADULT; AGED; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; FEMALE; FIBROBLASTS; GENE EXPRESSION; HAPLOTYPES; HUMANS; ITALY; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SKIN; SKIN NEOPLASMS;

EID: 84907858460     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12522     Document Type: Letter

References (29)

1. Bataille V, Lens M, Spector T D. J Eur Acad Dermatol Venereol 2012: 26: 1067-1073.
2. Council M L, Gardner J M, Helms C et al. Exp Dermatol 2009: 18: 485-487.
3. Hodis E, Watson I R, Kryukov G V et al. Cell 2012: 20: 251-263.
4. Puig-Butillé J A, Badenas C, Ogbah Z et al. Exp Dermatol 2013: 22: 148-150.
5. Lira M G, Provezza L, Malerba G et al. Exp Dermatol 2006: 15: 958-965.
6. Ibarrola-Villava M, Fernandez L P, Pita G et al. Exp Dermatol 2010: 19: 836-844.
7. Bishop D T, Demenais F, Iles M M et al. Nat Genet 2009: 41: 920-925.
8. Kunz M, Dannemann M, Kelso J. Exp Dermatol 2013: 22: 10-17.
9. Hassel J C, Amann P M, Schadendorf D et al. Exp Dermatol 2013: 22: 757-759.
10. Coussens L M, Werb Z. Nature 2002: 420: 860-867.
11. Meyer C, Sevko A, Ramacher M et al. Proc Natl Acad Sci USA 2011: 108: 17111-17116.
12. Zaidi M R, Hornyak T J, Merlino G. Pigment Cell Melanoma Res 2011: 24: 393-394.
13. Kvaskoff M, Whiteman D C, Zhao Z Z et al. Twin Res Hum Genet 2011: 14: 422-432.
14. Barrett J H, Iles M M, Harland M et al. Nat Genet 2011: 43: 1108-1113.
15. Zha S, Yegnasubramanian V, Nelson W G et al. Cancer Lett 2004: 215: 1-20.
16. Chwirot B W, Kuźbicki Ł. Melanoma Res 2007: 17: 139-145.
17. Minami S, Lum C A, Kitagawa K M et al. Int J Dermatol 2011: 50: 24-29.
18. Liao Z, Mason K A, Milas L. Drugs 2007: 67: 821-845.
19. Zhan H, Zheng H. Am J Clin Dermatol 2007: 8: 195-200.
20. Kosaka T, Miyata A, Ihara H et al. Eur J Biochem 1994: 221: 889-897.
21. Papafili A, Hill M R, Brull D et al. Arterioscler Thromb Vasc Biol 2002: 22: 1631-1636.
22. Ali I U, Luke B T, Dean M et al. Br J Cancer 2005: 93: 953-959.
23. Talar-Wojnarowska R, Gasiorowska A, Olakowski M et al. World J Gastroenterol 2011: 17: 4113-4117.
24. Coskunpinar E, Eraltan I Y, Turna A et al. Med Oncol 2011: 28: 1436-1440.
25. Zhang X, Miao X, Tan W et al. Gastroenterology 2005: 129: 565-576.
26. Mazzola S, Lira M G, Benedetti M D et al. Int J Immunogenet 2007: 34: 71-74.
27. Lira M G, Mazzola S, Tessari G et al. Br J Dermatol 2007: 157: 49-57.
28. Pfaffl M W. Nucleic Acids Res 2001: 29: e45.
29. Zhu W, Wei B B, Shan X et al. Mol Biol Rep 2010: 37: 277-288.